Suchergebnisse - "Candon, Sophie"

PubPharm (93)

71

Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease

enthalten in: Blood | 2010

von Aouba, A. | Georgin-Lavialle, S. | Pagnoux, C. | +14

72

Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease

enthalten in: Blood | 2010

von Aouba, A. | Georgin-Lavialle, S. | Pagnoux, C. | +14

73

Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients

enthalten in: Blood | 2010

von Keymeulen, B. | Candon, S. | Fafi-Kremer, S. | +15

74

Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients

enthalten in: Blood | 2010

von Keymeulen, B. | Candon, S. | Fafi-Kremer, S. | +15

75

FOXP3-enriched infiltrates associated with better outcome in renal allografts with inflamed fibrosis

enthalten in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 2009

von Zuber, J. | Brodin-Sartorius, A. | Lapidus, N. | +9

76

Rituximab in severe lupus nephritis : early B-cell depletion affects long-term renal outcome

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2009

von Melander, C. | Sallée, M. | Trolliet, P. | +16

77

12-month follow-up after successful infliximab therapy in pediatric crohn disease

enthalten in: Journal of pediatric gastroenterology and nutrition | 2008

von Wynands, J. | Belbouab, R. | Candon, S. | +8

78

CD3 antibodies as unique tools to restore self-tolerance in established autoimmunity their mode of action and clinical application in type 1 diabetes

enthalten in: Advances in immunology | 2008

von You, S. | Candon, S. | Kuhn, C. | +2

79

2 CD3 Antibodies as Unique Tools to Restore Self-Tolerance in Established Autoimmunity: Their Mode of Action and Clinical Application in Type 1 Diabetes

enthalten in: Advances in immunology | 2008

von You, S. | Candon, S. | Kuhn, C. | +2

80

Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome

enthalten in: Annals of the rheumatic diseases | 2007

von Seror, R. | Sordet, C. | Guillevin, L. | +9